Please assess the completion status of the following clinical trial:

Trial Title: The Effect of HMB Supplementation on Adipose Tissue Inflammation and Metabolism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Male~* Non-smoker~* Body mass index of 35-40 kg/m2~* Age 18-40 years~* Weight stable for past 6 months (\<5 lb. change)~* In good health, free of chronic diseases/conditions that may impact measured outcomes~* Willing and able to consume a weight loss diet~* Willing and able to consume a daily nutritional supplement (in pill form)~* Available for scheduled study commitments during the 2 months of study~Exclusion Criteria:~* Smoke~* Take any cholesterol lowering or weight loss drugs or an drugs or supplements that affect blood lipids, insulin or body composition~* Weigh greater 300 pounds due to weight, size and depth limitations of equipment~* Take dietary supplements~* Have a chronic disease such as:~* Cardiopulmonary disease (e.g. recent myocardial infarction, unstable angina, stroke) or unstable disease~* Severe orthopedic/musculoskeletal or neuromuscular impairments that would contradict exercise~* Sensory impairments that interfere with following directions~* Diagnosis if dementia~* History of malignancy during the past 5 years~* Diabetes mellitus

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Placebo Diet Restriction (Type: PLACEBO_COMPARATOR): None
- Placebo No Diet Restriction (Type: PLACEBO_COMPARATOR): None
- HMB Diet Restriction (Type: ACTIVE_COMPARATOR): None
- HMB No Diet Restriction (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).